Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.27
-0.09 (-1.01%)
Sep 22, 2026, 1:43 PM EDT - Market open
Haleon Market Cap
Haleon has a market cap or net worth of $40.38 billion as of September 22, 2026. Its market cap has decreased by -0.89% in one year.
Market Cap
40.38B
Enterprise Value
50.39B
1-Year Change
-0.89%
Ranking
Category
Stock Price
$9.27
ChartMarket Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $40.38B, an increase of 18.26%. That is a compound annual growth rate of 4.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 40.38B | -10.13% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 60.71B |
| Teva Pharmaceutical Industries | 45.42B |
| Zoetis | 29.50B |
| United Therapeutics | 21.22B |
| Viatris | 19.47B |
| Neurocrine Biosciences | 14.86B |
| Elanco Animal Health | 11.20B |
| Dr. Reddy's Laboratories | 10.17B |